Thus, based on the results of the enrichment analysis, we hypothesized that FUT4 plays a regulatory role in outcome in patients with rectal cancer by targeting immune-related processes and contributing to the tumor immune microenvironment. This evidence concerns the gene FUT4 and neoplasm.